Production (Stage)
SBC Medical Group Holdings Incorporated
SBC
$4.55
$0.7118.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.55% | -16.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.55% | -16.32% | |||
| Cost of Revenue | -9.03% | 7.13% | |||
| Gross Profit | 11.40% | -21.66% | |||
| SG&A Expenses | -54.84% | -2.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 219.29% | -235.75% | |||
| Total Operating Expenses | -6.16% | -37.21% | |||
| Operating Income | 22.38% | 42.95% | |||
| Income Before Tax | 419.06% | -53.77% | |||
| Income Tax Expenses | 2,138.37% | -104.76% | |||
| Earnings from Continuing Operations | 228.23% | 131.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 220.69% | -443.75% | |||
| Net Income | 228.82% | 130.83% | |||
| EBIT | 22.38% | 42.95% | |||
| EBITDA | 19.91% | 39.42% | |||
| EPS Basic | 227.36% | 113.42% | |||
| Normalized Basic EPS | -46.16% | 182.83% | |||
| EPS Diluted | 66.96% | 318.46% | |||
| Normalized Diluted EPS | -46.16% | 182.83% | |||
| Average Basic Shares Outstanding | 0.51% | 8.06% | |||
| Average Diluted Shares Outstanding | 0.51% | 8.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||